The crystal structure of YloQ, a circularly permuted GTPase essential for Bacillus subtilis viability

Journal of Molecular Biology
Vladimir M LevdikovAnthony J Wilkinson

Abstract

yloQ is one of 11 essential genes in Bacillus subtilis with unknown roles in the physiology of the cell. It encodes a polypeptide of 298 residues with motifs characteristic of GTPases. As a contribution to elucidating its indispensable cellular function, we have solved the crystal structure of YloQ to 1.6 A spacing, revealing a three-domain organisation. At the heart of the molecule is the putative GTPase domain, which exhibits a classical alpha/beta nucleotide-binding fold with a topology very similar to that of Ras and Era. However, as anticipated from the order in which the conserved G protein motifs appear in the sequence, the GTPase domain fold in YloQ is circularly permuted with respect to the classical GTPases. The nucleotide-binding pocket in YloQ is unoccupied, and analysis of the phosphate-binding (P) loop indicates that conformational changes in this region would be needed to accommodate GTP. The GTPase domain is flanked at its N terminus by a beta-barrel domain with an oligonucleotide/oligosaccharide-binding (OB) fold, and at its C terminus by an alpha-helical domain containing a coordinated zinc ion. This combination of protein modules is unique to YloQ and its orthologues. Sequence comparisons reveal a clustering ...Continue Reading

References

Nov 13, 1992·Cell·O TheunissenT Pieler
Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
May 1, 1995·Trends in Biochemical Sciences·C P Ponting, R B Russell
Jun 1, 1994·Trends in Biochemical Sciences·M Sprinzl
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·S Jones, J M Thornton
Jan 1, 1997·Annual Review of Biochemistry·S R Sprang
Jun 19, 1998·Current Opinion in Structural Biology·S J Gamblin, S J Smerdon
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·X ChenX Ji
Sep 15, 2000·Journal of Bacteriology·M ObuchowskiS J Séror
Nov 14, 2000·Journal of Bacteriology·Z Prágai, C R Harwood
Jan 3, 2001·Acta Crystallographica. Section D, Biological Crystallography·T J Oldfield
Nov 10, 2001·Science·I R Vetter, A Wittinghofer
Dec 26, 2001·Chemical Reviews·L N Johnson, R J Lewis
Mar 28, 2002·Journal of Molecular Biology·Detlef D LeipeL Aravind
Apr 16, 2002·Molecular Microbiology·R Allyn ForsythJudith W Zyskind
Apr 27, 2002·Journal of Bacteriology·Jacqueline TanJames C A Bardwell
May 31, 2002·Acta Crystallographica. Section D, Biological Crystallography·Thomas J Oldfield
Sep 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Brian E HallNicolas Nassar
Sep 28, 2002·Acta Crystallographica. Section D, Biological Crystallography·Thomas R Schneider, George M Sheldrick
Dec 7, 2002·Structure·Victoria L RobinsonAnn M Stock
Jan 16, 2003·Nucleic Acids Research·S Sri KrishnaNick V Grishin
Feb 25, 2003·Annual Review of Biophysics and Biomolecular Structure·Douglas L TheobaldDeborah S Wuttke
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·K KobayashiN Ogasawara
May 7, 2003·Current Opinion in Microbiology·Catherine E Caldon, Paul E March
Jul 3, 2003·Journal of Bacteriology·Alexey TeplyakovGary L Gilliland
Jul 16, 2003·Cell·Andrey V Zavialov, Måns Ehrenberg
Oct 22, 2003·Journal of Molecular Biology·Detlef D LeipeL Aravind
Dec 23, 2003·The Journal of Biological Chemistry·Antonina Roll-MecakStephen K Burley

❮ Previous
Next ❯

Citations

Jul 19, 2005·Archives of Microbiology·Adam IwanickiMichal Obuchowski
Feb 18, 2006·Molecular Genetics and Genomics : MGG·Lionel CladièreSimone J Séror
Jul 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qiang GuoNing Gao
Sep 20, 2008·The Journal of Biological Chemistry·Magali MoreauDaniel F Klessig
Mar 20, 2013·Journal of Biochemistry·Simon GotoHyouta Himeno
Oct 7, 2004·Nucleic Acids Research·Hyouta HimenoAkira Muto
Nov 17, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·C E NicholsD K Stammers
Jul 25, 2006·Infection and Immunity·Tracey L CampbellEric D Brown
Apr 28, 2009·Journal of Bacteriology·Michel DébarbouilléBertrand Duclos
Mar 18, 2008·Journal of Bacteriology·Cédric AbsalonSimone J Séror
Jun 22, 2005·Journal of Bacteriology·Cristina BongiorniMarta Perego
Sep 3, 2011·Microbiology and Molecular Biology Reviews : MMBR·Natalie VerstraetenJan Michiels
Nov 17, 2007·BMC Structural Biology·Alexej Abyzov, Valentin A Ilyin
Jun 17, 2011·Annual Review of Biochemistry·Alfred Wittinghofer, Ingrid R Vetter
Aug 30, 2008·Journal of Molecular Recognition : JMR·Chia-Han ChuTun-Wen Pai
Nov 26, 2010·The EMBO Journal·Simon GotoHyouta Himeno
Nov 26, 2011·Journal of Molecular Biology·Vladimir M LevdikovAnthony J Wilkinson
Jun 9, 2009·Journal of Molecular Biology·Vladimir M LevdikovAnthony J Wilkinson
Jul 1, 2008·Journal of Molecular Biology·Takatsugu KimuraHyouta Himeno
May 22, 2007·Biopolymers·Katrin Karbstein
Dec 8, 2005·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Eric D Brown
Jan 18, 2006·The New Phytologist·John A Raven, John Beardall
Jun 15, 2007·Critical Reviews in Biochemistry and Molecular Biology·Daniel N Wilson, Knud H Nierhaus
Apr 15, 2005·The Biochemical Journal·Tracey L CampbellEric D Brown
Apr 12, 2017·Proceedings of the National Academy of Sciences of the United States of America·Aida RaziJoaquin Ortega
Feb 11, 2005·Chemical Reviews·Eric D Brown, Gerard D Wright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.